Mengmeng Yang

发表

A subset of gastric cancers with EGFR amplification and overexpression respond to cetuximab therapy

Yiqiang Liu, Jiafu Ji, Lianhai Zhang, 2013, Scientific Reports.

NSCLC harboring EGFR exon‐20 insertions after the regulatory C‐helix of kinase domain responds poorly to known EGFR inhibitors

Xiaoxi Xu, Qi-Xiang Li, Jinying Ning, 2016, International journal of cancer.

Overcoming erlotinib resistance with tailored treatment regimen in patient‐derived xenografts from naïve Asian NSCLC patients

Junjie Lu, B. Shan, Taiping Chen, 2013, International journal of cancer.